CAPSULAR POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES OF VIBRIO VULNIFICUS
CAPSULAR POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES OF VIBRIO VULNIFICUS
批准号:
3748114
负责人:
S DEVI
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
创伤弧菌引起致命的败血症和伤口感染
英文摘要
Vibrio vulnificus causes fatal septicemic and wound infections in
immunocompromised humans following raw oyster consumption or exposure of
open wounds to oyster-harvested waters. The capsular polysaccharide of
Vibrio vulnificus (VvPS) is believed to confer the property of
invasiveness. With the objective of evaluating the pathogenic and
protective roles of VvPS and other protein antigens of V. vulnificus, we
synthesized conjugate vaccines of carbotype 1 VvPS with TT or inactivated
cytolysin or elastase of V. vulnificus by two different schemes. The
immunogenicity of these conjugates was evaluated in Swiss shite mice by
subcutaneous injections in saline. All conjugates elicited higher
capsular antibody responses than VvPS alone and induced elevated IgG and
IgM responses. The conjugates prepared through carboxyl activation of
VvPS (VvPS-TTa, VvPS-cytolysin and VvPS-elastase) were more immunogenic
than the one prepared through hydroxyl activation (VvPS-TTb). Capsular
antibody response was significantly enhanced by concurrent
intraperitoneal administration of conjugates with MPL+TDM adjuvant.The
individual and synergistic protective effects of VvPS, cytolysin and
elastase alone and in conjugate vaccine forms were evaluated in a mouse
septicemia model. VvPS-TTa vaccine conferred protection to 80% of
actively immunized mice following intraperitoneal infection with -5 LD50
of carbotype 1 V. vulnificus, while the protection conferred by VvPS-
cytolysin and VvPS-elastase was 40 and 44% respectively. VvPS-TTb was
least protective. Control mice immunized with VvPS, cytolysin or
elastase alone, VvPS followed by cytolysin, or saline only, showed 70-
100% mortality. Thus, VvPS-TTa is highly immunogenic and protective in
mice, and appears suitable for clinical evaluation. Passive protection
studies using VvPS-TTa-induced antisera are underway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRICHOSPORON BIEGELII PS CROSS REACTS WITH CRYPTOCOCCAL CAPSULAR ANTIGEN
-
批准号:3748115
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
IMMUNE RESPONSE TO GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE
-
批准号:3748105
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
IMMUNE RESPONSE TO GROUP B MENINGOCOCCAL POLYSACCHARIDE
-
批准号:3792319
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
CAPSULAR POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES OF VIBRIO VULNIFICUS
-
批准号:5200680
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
PRECLINICAL SAFETY AND IMMUNOGENICITY OF GROUP B MENINGOCOCCAL VACCINES
-
批准号:2568873
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
TRICHOSPORON BIEGELII PS CROSS REACTS WITH CRYPTOCOCCAL CAPSULAR ANTIGEN
-
批准号:5200681
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
PRECLINICAL SAFETY AND IMMUNOGENICITY OF GROUP B MENINGOCOCCAL VACCINES
-
批准号:5200675
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
IMMUNE RESPONSE TO GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE
-
批准号:3770275
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S DEVI
-
依托单位:--
海外基金